A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBD09

Clinical trial NCT07094932 · COMPLETED

Trial details

NCT number: NCT07094932
Sponsor: Gates Medical Research Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Participants

Start date: 2025-09-03
Primary completion: 2026-01-11
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.